Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mateus Fuchshuber-Moraes"'
Autor:
Renata B. V. Abreu, Thiago T. Gomes, Thales C. Nepomuceno, Xueli Li, Mateus Fuchshuber-Moraes, Giuliana De Gregoriis, Guilherme Suarez-Kurtz, Alvaro N. A. Monteiro, Marcelo A. Carvalho
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
BRCA1 is a major tumor suppressor that functions in the accurate repair of DNA double-strand breaks via homologous recombination (HR). Nonsense mutations in BRCA1 lead to inactive truncated protein products and are associated with high risk of breast
Externí odkaz:
https://doaj.org/article/7d50829b184947b5905f3922f653d4a3
Autor:
Sérgio D J Pena, Giuliano Di Pietro, Mateus Fuchshuber-Moraes, Julia Pasqualini Genro, Mara H Hutz, Fernanda de Souza Gomes Kehdy, Fabiana Kohlrausch, Luiz Alexandre Viana Magno, Raquel Carvalho Montenegro, Manoel Odorico Moraes, Maria Elisabete Amaral de Moraes, Milene Raiol de Moraes, Elida B Ojopi, Jamila A Perini, Clarice Racciopi, Andrea Kely Campos Ribeiro-Dos-Santos, Fabrício Rios-Santos, Marco A Romano-Silva, Vinicius A Sortica, Guilherme Suarez-Kurtz
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17063 (2011)
Based on pre-DNA racial/color methodology, clinical and pharmacological trials have traditionally considered the different geographical regions of Brazil as being very heterogeneous. We wished to ascertain how such diversity of regional color categor
Externí odkaz:
https://doaj.org/article/47d5071fbd074d108b6a70080571e9a6
Autor:
Renata B V, Abreu, Thiago T, Gomes, Thales C, Nepomuceno, Xueli, Li, Mateus, Fuchshuber-Moraes, Giuliana, De Gregoriis, Guilherme, Suarez-Kurtz, Alvaro N A, Monteiro, Marcelo A, Carvalho
Publikováno v:
Frontiers in pharmacology. 13
BRCA1 is a major tumor suppressor that functions in the accurate repair of DNA double-strand breaks via homologous recombination (HR). Nonsense mutations in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7aa173603fc7b652896f56ceaad7e524
https://pubmed.ncbi.nlm.nih.gov/35837282
https://pubmed.ncbi.nlm.nih.gov/35837282
Publikováno v:
Pharmacogenetics and Genomics. 26:363-369
Objective Several algorithms have been proposed to reduce the genotyping effort and cost, while retaining the accuracy of N-acetyltransferase-2 (NAT2) phenotype prediction. Data from the 1000 Genomes (1KG) project and an admixed cohort of Black Brazi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b7f6b4e10ffd2156b4197340f40242e
https://doi.org/10.1097/fpc.0000000000000225
https://doi.org/10.1097/fpc.0000000000000225
Autor:
Andreia Cristina de Melo, Rachele Grazziotin-Reisner, Guilherme Suarez-Kurtz, Mateus Fuchshuber-Moraes, Mariane Fontes Dias, Juliane Morando, Michel P. Carneiro, Carlos Gil Ferreira, Bruna Novaes Neto, Flávia Vieira Guerra Alves, Alvaro Henrique Ingles Garces, Giulliana Moralez, Felipe Erlich
Publikováno v:
Cancer chemotherapy and pharmacology. 78(1)
Cervix cancer (CC) represents the fourth most common cancer in women. Treatment involving cisplatin and radiotherapy has been the standard for locally advanced disease. Everolimus inhibits the aberrant activity of mTOR that is part of carcinogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678343e7333d7eb29b282234efe19c1e
https://pubmed.ncbi.nlm.nih.gov/27206639
https://pubmed.ncbi.nlm.nih.gov/27206639
Publikováno v:
European Journal of Clinical Pharmacology. 65:789-793
To explore the pharmacogenomics of warfarin using the extreme-discordant-phenotype (EDP) methodology. The target phenotype was the stable warfarin dose prescribed to 353 patients. Pharmacogenetic polymorphisms assessed were coagulation factor VII (FV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b26335dd2e429fa955202923199c3fc
https://doi.org/10.1007/s00228-009-0651-6
https://doi.org/10.1007/s00228-009-0651-6
Autor:
Marcelo A. Carvalho, Renato S. Carvalho, Mateus Fuchshuber-Moraes, Guilherme Suarez-Kurtz, Christian Rimmbach, Dieter Rosskopf
Publikováno v:
Pharmacogenetics and genomics. 21(11)
Background CYP2C19 is a polymorphic enzyme that plays a pivotal role in the metabolism of 10% of clinically used drugs worldwide. The CYP2C19*3 allele is characterized by a premature stop codon that leads to a truncated nonfunctional protein and cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d58cb2101df7481db06965928abf1a
https://pubmed.ncbi.nlm.nih.gov/21934639
https://pubmed.ncbi.nlm.nih.gov/21934639
Autor:
Marco Aurélio Romano-Silva, Maria Elisabete Amaral de Moraes, Fabrício Rios-Santos, Luiz Alexandre V. Magno, Clarice Racciopi, Fernanda S G Kehdy, Elida B. Ojopi, Manoel Odorico de Moraes, Vinicius A. Sortica, Raquel Carvalho Montenegro, Giuliano Di Pietro, Sérgio D.J. Pena, Jamila Alessandra Perini, Julia P. Genro, Milene Raiol de Moraes, Ândrea Ribeiro-dos-Santos, Guilherme Suarez-Kurtz, Mara H. Hutz, Fabiana B. Kohlrausch, Mateus Fuchshuber-Moraes
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17063 (2011)
PLoS ONE
PLoS ONE
Based on pre-DNA racial/color methodology, clinical and pharmacological trials have traditionally considered the different geographical regions of Brazil as being very heterogeneous. We wished to ascertain how such diversity of regional color categor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93154cf6e0f7b3b6b6fb4fc61ef9f70b
https://doi.org/10.1371/journal.pone.0017063
https://doi.org/10.1371/journal.pone.0017063